4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-041828
Chief Medical Officer sold 6,250 shares at an average $47.33 ($295,789)
- Chief Medical Officer acquired 6,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BALDO LANCE Chief Medical Officer | 2020-07-06 | Option exercise | +6,250 | $7.80 | $48,750 | 6,250 | D: show line 1 in the form |
| BALDO LANCE Chief Medical Officer | 2020-07-06 | Sale | −6,050 | $47.29 | $286,105 | 200 | D: show line 2 in the form |
| BALDO LANCE Chief Medical Officer | 2020-07-06 | Sale | −200 | $48.42 | $9,684 | 0 | D: show line 3 in the form |
| Open-market sales · 6,250 sh · avg $47.33 · $295,789 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BALDO LANCE Chief Medical Officer | 2020-07-06 | Option exercise · Stock Option (Right to Buy) | −6,250 | 437,500 | D: show line 4 in the form |
Loading xslF345X03/doc4.xml…